Physician

Sanju Andrew Varghese, MD

According to 2025 Medicare claims, Sanju Varghese, MD (NPI: 1780629956) practices nephrology in the Springfield, OH market, with the plurality of this provider's patient population coming from Clark, OH. This provider's primary affiliated billing organization is ADVANCED NEPHROLOGY & HYPERTENSION (NPI: 1780069567; TIN: 320465385) and primary practice location at 45504-2687. Varghese is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Varghese's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 475 traditional Medicare patients, billed 2,345 HCPCS/CPT codes, and received $173,699 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 4,604 prescription claims across 643 beneficiaries totaling $1,173,660 in drug costs, led by Jynarque (Tolvaptan). DME data shows 11 claims. Open Payments data shows 85 records totaling $6,094. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $418,776 to $1,173,660. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $475 to $5,659.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$134K$268K2015 Medicare payment: $180,502 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $197,370 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $236,351 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $242,625 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $268,448 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $224,208 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $227,916 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $190,694 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $155,676 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $173,699 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154802,180$180,502
20165402,239$197,370
20175412,828$236,351
20185712,717$242,625
20196093,037$268,448
20205512,469$224,208
20215702,679$227,916
20225562,453$190,694
20235111,976$155,676
20244752,345$173,699

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$587K$1.2M2015 Drug cost: $418,776 (USD; Tot_Drug_Cst)2016 Drug cost: $408,549 (USD; Tot_Drug_Cst)2017 Drug cost: $378,388 (USD; Tot_Drug_Cst)2018 Drug cost: $420,488 (USD; Tot_Drug_Cst)2019 Drug cost: $700,121 (USD; Tot_Drug_Cst)2020 Drug cost: $706,656 (USD; Tot_Drug_Cst)2021 Drug cost: $572,869 (USD; Tot_Drug_Cst)2022 Drug cost: $762,991 (USD; Tot_Drug_Cst)2023 Drug cost: $792,116 (USD; Tot_Drug_Cst)2024 Drug cost: $1,173,660 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153535,292$418,776
20164055,354$408,549
20174494,763$378,388
20185184,609$420,488
20195604,195$700,121
20205464,399$706,656
20215624,497$572,869
20225814,317$762,991
20236104,328$792,116
20246434,604$1,173,660

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.2K$2.4K2017 Medicare payment: $506 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $690 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,222 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $2,432 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $243 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R28$506
2018N/RN/RN/R
2019N/R11$690
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R12$2,222
2023N/R12$2,432
2024N/R11$243

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes129156$96
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes110425$90
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more246391$74
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more182215$40
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's282512$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JynarqueTolvaptan13390$268,957
FarxigaDapagliflozin Propanediol19212,067$221,545
KerendiaFinerenone924,054$86,264
JardianceEmpagliflozin614,060$79,094
OzempicSemaglutide401,344$37,791

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J7517Mycophenolate mofetil, oral, 250 mgNN/R11$243

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.85$6,094AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sanju Andrew Varghese, MD?

Tedicare shows public-source Medicare data for Sanju Andrew Varghese, MD (NPI 1780629956), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sanju Andrew Varghese, MD have ACO affiliation data?

Sanju Andrew Varghese, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Sanju Andrew Varghese, MD?

Sanju Andrew Varghese, MD is linked to ADVANCED NEPHROLOGY & HYPERTENSION (billing NPI 1780069567) in the available physician profile data.

Does Sanju Andrew Varghese, MD have Open Payments data?

Sanju Andrew Varghese, MD has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.